Canada · Health Canada Drug Product Database

APRETUDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 103643
DIN: 02547473
Form: Suspension (Extended-Release)
Company as listed by source: VIIV HEALTHCARE ULC
Source status: Marketed (2024-06-19)
Source last updated: 2025-09-22

Source-listed ingredients

CABOTEGRAVIR — 200 MG — per 1 ML

These values do not establish equivalence or a dose recommendation.

Packages

Package details are not available in this snapshot.

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →